Previous Close | 6.06 |
Open | 6.03 |
Bid | 5.80 x 800 |
Ask | 6.10 x 800 |
Day's Range | 5.82 - 6.04 |
52 Week Range | 5.01 - 11.48 |
Volume | |
Avg. Volume | 446,614 |
Market Cap | 370.141M |
Beta (5Y Monthly) | 2.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.54 |
Earnings Date | Feb 05, 2024 - Feb 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 31.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for CMPS
LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference at 10:25 am ET on November 30, 2023. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the Compass website. The replay of the webcast wi
UK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study Research will take place in the UK, including at the newly opened Centre for Mental Health Research and Innovation in London, developed in partnership with South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Com
COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded. I would now like to introduce your host […]